‘Game-changing’ results from the world’s largest prostate cancer clinical trial have just been released. The first results from the much-anticipated STAMPEDE trial were announced yesterday and show clearly that giving docetaxel chemotherapy alongside hormone therapy can extend men's lives.
Keyline has organised an annual car rally to different destinations across Europe since 2010 and this promises to be the best yet. During the last five years we have raised an incredible £1 Million for Prostate Cancer UK.
Yes-Sir.com announce that they'll donate £4 from every fragrance sale on their website between now and 18 June to Prostate Cancer UK.
It’s great news that NICE has listened to us and developed a reference guide so doctors and hospitals know the five most important things to do to achieve quality care for men with prostate cancer.
It’s not been a good week for men. Hot on the heels of two other disappointing decisions), NICE (the National Institute of Health and Care Excellence) has just announced their intention not to make enzalutamide routinely available to men with advanced prostate cancer who haven’t had chemotherapy.
Prostate cancers can run, but they can no longer hide. For the first time, researchers have found a way to target individual prostate cancer sites in other parts of the body. We take a look at the science behind this headline-grabbing story and ask if it lives up to the media fanfare.
BLOG: What’s involved in creating one of our information resources? Well, how about 12 health professionals, one partner organisation, several patient reviewers and a designer. They all helped to create our latest resource: Find out about Your prostate, an Easy Read guide for men with learning disabilities.
An amazing 246 Deloitte staff will be taking part in four challenges across four continents to raise £1 million for Prostate Cancer UK, Alzheimer’s Society, and Mind.